MedTrace Logo

Caudal Dexmedetomidine vs Ketamine for Postoperative Analgesia in Pediatric DDH Surgery

NCT07385352 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2026-02-04

No results posted yet for this study

Summary

This study compares two medicines, Dexmedetomidine and Ketamine, added to caudal Bupivacaine to control pain after hip surgery in children. We will check how well each medicine reduces pain, how long the pain relief lasts, and if children need extra pain medicine. The goal is to find the safest and most effective option for postoperative pain relief in children undergoing hip surgery.

Conditions

  • Developmental Dysplasia of the Hip

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine 1 µg/kg added to caudal Bupivacaine.

DRUG

Ketamine

Ketamine 0.5 mg/kg added to caudal Bupivacaine.

DRUG

Bupivacaine

Isobaric Bupivacaine 0.25% 1 ml/kg used for caudal block in both groups.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Esraa Abdelmonem, MSc · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-08-31
Completion
2026-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07385352 on ClinicalTrials.gov